Diseases and Conditions Information
Diseases and Conditions Information.
Quick Links:  Asthma & Allergies |  Cancer  |  Depression  |  Anxiety  |  Diabetes  
BROWSE DISEASES AND CONDITIONS DIRECTORY
Medical Resource for all diseases and conditions information - cancer, neurological disorders, birth defects, AIDS, alzheimer's.

ADD and ADHD
Adrenal
AIDS
Allergies
Anxiety
Birth Defects
Blood Disorders
Cancer
Cardiovascular Disorders
Communication Disorders
Depressive Disorders
Diabetes
Digestive Disorders
Dyslexia
Ear, Nose & Throat Disease
Endocrine Disorders
Endometriosis
Eye Disorders
Genetic Disorders
Genitourinary Disorders
Halitosis
Hangover
Hemorrhoids
Hormonal Disorders
Immune Disorders
Infectious Diseases
Insulin Resistance
Miscellaneous
Musculoskeletal Disorders
Neurological Disorders
Nutrition Disorders
Organizations
Parathyroid
Pituitary
Polycystic Ovarian Syndrome
Pregnancy Complications
Premature Ejaculation
Rare Disorders
Registries
Conditions & Diseases Resources
Respiratory Disorders
Sexual Transmitted Diseases
Skin Disorders
Sleep Disorders
Thyroid
Wounds & Injuries

Hansen's Diseases
Outlines the symptoms, testa/diagnosis, causes and risk factors and treatment of this diseases
Agoraphobia
All about Agoraphobia - Anxiety, Dyspnea, Stress, all are symptoms of treatable depression
Down Syndrome
Learn about this genetic disorder, the causes and medical treatment
DISEASES AND CONDITIONS NEWS  
FDA approves Medtronic's 'artificial pancreas' for diabetes
Medtronic Plc won U.S. approval on Wednesday for an "artificial pancreas" that is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes, freeing them from continually monitoring insulin levels throughout each day. The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670G, hailed it as a breakthrough. The device offers type 1 diabetics "greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," Dr. Jeffrey Shuren, director of the FDA's medical device division, said in a statement.

FDA approves 'artificial pancreas' to manage diabetes
<p><a href="http://news.yahoo.com/fda-approves-device-automatically-manage-191338168.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ps9WZwcLogBpABDKZ_AXZw--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cHhvZmY9NTA7cHlvZmY9MDtxPTc1O3c9MTMw/http://media.zenfs.com/en_us/News/ap_webfeeds/6a1e90187686433badc1cff63dd47d95.jpg" width="130" height="86" alt="This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)" align="left" title="This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)" border="0" /></a>WASHINGTON (AP) — Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed.</p><br clear="all"/>

Exercise found to reduce fatigue and improve physical fitness in women undergoing breast cancer treatments
<p><a href="http://news.yahoo.com/exercise-found-reduce-fatigue-improve-physical-fitness-women-170213939.html"><img src="http://l1.yimg.com/bt/api/res/1.2/XUO5kS9rVzOoFcMCOrfFUA--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_US/News/US-AFPRelax/istock_00006288.46a9d114511.original.jpg" width="130" height="86" alt="Exercise also appeared to slightly improve cognitive function." align="left" title="Exercise also appeared to slightly improve cognitive function." border="0" /></a>Breast Cancer Awareness Month kicks off in October to raise awareness about the disease, its signs, symptoms, screening and diagnosis. Ahead of this, an extensive British review -- based on 32 clinical trials covering 2,626 women -- has highlighted the advantages of exercise for women in all stages of the disease. The review collates various studies focusing on women undergoing very different kinds of therapy and surgery for breast cancer.</p><br clear="all"/>

Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety. Just 4 percent to 20 percent of participants may see their cancer respond to the drug, the authors write in the journal Cancer.

Kite immunotherapy drug helps blood cancer patients in study
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of the news, rose 11 percent when trading resumed. Some 76 percent of patients taking the drug, called KTE-C19, showed significant tumor shrinkage, including 47 percent who had no remaining signs of cancer at least three months after receiving the treatment, Kite said.

Fungus identified as key factor in the development of Crohn's disease
<p><a href="http://news.yahoo.com/fungus-identified-key-factor-development-crohns-disease-162205391.html"><img src="http://l2.yimg.com/bt/api/res/1.2/avG04EG1A9hQ5npZyX6GTQ--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_US/News/US-AFPRelax/istock_87353741.0c974103208.original.jpg" width="130" height="86" alt="Genetic and environmental factors also play a role in Crohn’s disease." align="left" title="Genetic and environmental factors also play a role in Crohn’s disease." border="0" /></a>Recent medical research has focused on links between the fungal composition of human microbiota and chronic inflammatory bowel disease. A research team in Cleveland, USA, has identified one specific fungus as a key factor in the development of Crohn&#039;s disease. &quot;We already know that bacteria, in addition to genetic and dietary factors, play a major role in causing Crohn&#039;s disease,&quot; said the study&#039;s senior and corresponding author, Mahmoud A Ghannoum, PhD, professor and director of the Center for Medical Mycology at Case Western Reserve and University Hospitals Cleveland Medical Center.</p><br clear="all"/>

Ivory Coast rain boosts cocoa crop, sun needed to avoid disease
<p><a href="http://news.yahoo.com/ivory-coast-rain-boosts-cocoa-crop-sun-needed-151601600--sector.html"><img src="http://l3.yimg.com/bt/api/res/1.2/lRXP2gUkVDp.oJENrI2Z3g--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-09-26T151601Z_1_LYNXNPEC8P0UK_RTROPTP_2_COCOA-IVORYCOAST-MIDCROP.JPG" width="130" height="86" alt="Cocoa pod and cherelles are seen at a plantation in Soubre" align="left" title="Cocoa pod and cherelles are seen at a plantation in Soubre" border="0" /></a>Heavy rain that continued last week in most of Ivory Coast&#039;s main cocoa growing regions will improve the size of the upcoming main crop, farmers said on Monday, but more sun is needed to ward off disease. Some farmers said they had already started harvesting and selling small amounts of beans to pay expenses such as children&#039;s school fees. In the southern region of Aboisso, farmers said they were optimistic about the main crop outlook but concerned about poor bean quality due to lack of sun.</p><br clear="all"/>

FDA approves J&J's autoimmune drug Stelara for Crohn's disease
<p><a href="http://news.yahoo.com/fda-approves-j-js-autoimmune-drug-stelara-crohns-141305541--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/VuNe2nZqZ_tOIvPlTSRzvQ--/YXBwaWQ9eW5ld3NfbGVnbztmaT1maWxsO2g9ODY7cT03NTt3PTEzMA--/http://media.zenfs.com/en_us/News/Reuters/2016-09-26T141305Z_1_LYNXNPEC8P0SC_RTROPTP_2_SWISS-BUSINESS.JPG" width="130" height="86" alt="Logo of healthcare company Johnson &amp; Johnson is seen in Zug" align="left" title="Logo of healthcare company Johnson &amp; Johnson is seen in Zug" border="0" /></a>(Reuters) - Johnson &amp; Johnson said on Monday that the U.S. Food and Drug Administration approved the company&#039;s blockbuster psoriasis drug, Stelara, for use in adults with Crohn&#039;s disease. The drug is approved in the United States to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis. Crohn&#039;s is a chronic inflammatory condition in the gastrointestinal tract, causing abdominal pain, diarrhea, rectal bleeding, weight loss and fever.</p><br clear="all"/>


Health Directory | About Us | Submit Your Site | How to link to us | Contact Us
DiseasesConditions lists all the major web sites and companies for practically every country in the world. Browse our massive index of thousands of dedicated diseases and conditions web sites. All logos, trademarks and other propriety marks belong to their respective owners and do not reflect an association or recommendation by any of the parties.
©2005 DiseasesConditions.com - All Rights Reserved.